A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

Condition:   Acromegaly Intervention:   Drug: CAM2029 (octreotide subcutaneous depot) Sponsor:   Camurus AB Recruiting

Source: ClinicalTrials.gov - October 14, 2019 Category: Research Source Type: clinical trials